Bittencourt P R, Richens A
Arq Neuropsiquiatr. 1985 Mar;43(1):11-6. doi: 10.1590/s0004-282x1985000100002.
Single doses of phenytoin (500 and 1.000 mg), carbamazepine 400 and 1.00 mg) and sodium valproate (600 mg) were given orally to 5 healthy young volunteers and serum concentrations determined between 1-8h after administration. The design was double-blind and placebo-controlled. Serum concentrations considered "therapeutic" were obtained after sodium valproate and the 100 mg dose of carbamazepine. The results suggest the loading-doses of phenytoin (1500-2000 mg) and carbamazepine (800 mg) are useful in the subacute control of frequent epileptic seizures on an out-patient basis, and that carbamazepine may be used for lasting control of seizures of status epilepticus treated initially with diazepam or other rapidly-acting preparation.
给5名健康年轻志愿者口服单剂量的苯妥英(500毫克和1000毫克)、卡马西平(400毫克和1000毫克)和丙戊酸钠(600毫克),并在给药后1至8小时测定血清浓度。该设计为双盲且有安慰剂对照。丙戊酸钠和100毫克剂量的卡马西平给药后获得了被认为“治疗性”的血清浓度。结果表明,苯妥英(1500 - 2000毫克)和卡马西平(800毫克)的负荷剂量对于门诊频繁癫痫发作的亚急性控制是有用的,并且卡马西平可用于对最初用安定或其他速效制剂治疗的癫痫持续状态发作的持久控制。